Logo
DCA

Johnson & Johnson

JNJ0.FHealthcareDrug Manufacturers - General
€17.40
-1.14%
Last Price
€17.40
2026-06-02
24h Change
-1.14%
-0.20 EUR
Volume
6
Shares Traded
Data Reliability
Medium
676 points (3 years)

Price History

Start a simulation with this asset

JNJ0.F

Global parameters

Available data from 9/29/2023 to 6/2/2026

Fundamental Analysis

New
CAGR (5y)
5.60%
Revenue Growth
Net Margin
28.46%
Profitability
ROE
32.87%
Return on Equity
Debt / EBITDA
1.17
Solvency
PEG Ratio
2.79
Valuation vs Growth
Rev. Growth (TTM)
9.90%
Current Trend

PE Ratio History (5 Years)

Historical PE
Average (17.6x)
Current: 24.7x
Technical focus
JNJ0.F
30d volatility
29.14%
Distance to MA50
-4.86%
Distance to MA200
4.40%
Distance to ATH
-13.00%
Momentum 3M
-10.77%
Risk score
N/A

Volatility moderate. Momentum neutral.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Invest in this asset
Buy on Saxo Bank
🏦Regulated Broker
🌍Global Markets Access
📈Pro Tools

Ad link. Capital at risk.

Technical Analysis & Risk

Key Metrics

CAGR7.23%
Volatility29.14%
Max Drawdown-21.63%

Momentum : JNJ0.F

Indicateur synthétique
PEURNEUTREAVIDITÉ
51
Neutral

Risk Analysis

VaR (95%)-2.63%
DCA Health
95/100

Recent History (60 days)

DateCloseVolume
2026-06-02€17.406
2026-06-01€17.606
2026-05-29€18.006
2026-05-28€0.006
2026-05-27€18.000
2026-05-26€18.206
2026-05-25€18.506
2026-05-22€18.206
2026-05-21€18.006
2026-05-20€18.106
2026-05-19€17.906
2026-05-18€17.806
2026-05-15€18.306
2026-05-14€18.106
2026-05-13€17.506
2026-05-12€17.406
2026-05-11€17.406
2026-05-08€17.506
2026-05-07€18.506
2026-05-06€17.70200
2026-05-05€17.70200
2026-05-04€17.80200
2026-04-30€17.80200
2026-04-29€17.90200
2026-04-28€17.70200
2026-04-27€17.90200
2026-04-24€18.20200
2026-04-23€17.80200
2026-04-22€17.80200
2026-04-21€18.10200
2026-04-20€18.30200
2026-04-17€18.30200
2026-04-16€18.50200
2026-04-15€18.50200
2026-04-14€18.50200
2026-04-13€18.50200
2026-04-10€18.90200
2026-04-09€18.70200
2026-04-08€18.60200
2026-04-07€19.10200
2026-04-02€19.30200
2026-04-01€19.40200
2026-03-31€19.40200
2026-03-30€19.30200
2026-03-27€19.00200
2026-03-26€19.00200
2026-03-25€18.80200
2026-03-24€18.70200
2026-03-23€18.70200
2026-03-20€19.00200
2026-03-19€19.10200
2026-03-18€19.10200
2026-03-17€20.00200
2026-03-16€19.30207
2026-03-13€19.60207
2026-03-12€19.50207
2026-03-11€19.50207
2026-03-10€19.300
2026-03-09€19.00207
2026-03-06€19.000

Recent Dividends

DateAmount
2026-05-26+€0.11
2026-02-24+€0.10
2025-11-25+€0.10
2025-08-26+€0.10
2025-05-27+€0.11
2025-02-18+€0.10
2024-11-26+€0.10
2024-08-27+€0.10
2024-05-17+€0.10
2024-02-16+€0.10
2023-11-20+€0.10

Related Assets